Chinese consensus on therapeutic drug monitoring of targeted drugs for the treatment of gastrointestinal stromal tumors

Title: Chinese consensus on therapeutic drug monitoring of targeted drugs for the treatment of gastrointestinal stromal tumors
Edition: Original
Classification: Experts consensus
Field: Treatment
Countries and regions: China
Guidelines users: Doctors, pharmacists, nurses and laboratory technicians in various medical institutions involved in the treatment and management of gastrointestinal stromal tumors
Evidence classification method: GRADE
Development unit: 中国药学会医院药学专业委员会;中国药理学会治疗药物监测研究专业委员会;中国医师协会外科医师分会胃肠道间质瘤诊疗专业委员会;
Registration time: 2021-03-29
Registration number: IPGRP-2021CN075
Purpose of the guideline: To formulate the technical specifications of therapeutic drug monitoring for targeted drugs in the treatment of gastrointestinal stromal tumors including timing, frequency and indicators, as well as the interpretation of the results and the clinical application, guiding the individualized therapy and whole-course management of such patients